No matter what the preclinical model looks like, when you put it in humans, it acts differently and the phase one trials are the ones where they need the most monitoring, the most procedures, the most careful oversight, the trials I've worked on, the end result... the dosing toxicities were not what...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
